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E3-deleted canine adenovirus type 1 (CAV-1) was generated by homologous recombination in bacterial cells, using an
antibiotic resistance marker to facilitate the recovery of recombinants. This marker was flanked by unique restriction
endonuclease sites, which allowed its subsequent removal and the insertion of cassettes expressing the canine parvovirus
capsid at the E3 locus. Infectious virus was recovered following transfection of canine cells and capsid expression was
observed by RT-PCR from one of the virus constructs. A second construct, containing a different promoter, showed delayed
growth and genome instability which, based on the size difference between these inserts, suggests a maximum packagingIntroduction. Adenoviruses (Ads), in particular those
infecting domesticated animals, have received much in-
terest as replication-competent vaccine vectors for the
delivery of heterologous antigens in the natural host
(Reddy et al., 1999; Tuboly and Nagy, 2001). Such vectors
can potentially elicit both humoral and cell-mediated
immunity to the Ad and expressed antigen(s). In addition,
as most Ads can infect and replicate within the respira-
tory epithelium, vaccination could provide local mucosal
immunity, which is an important first line of defence. Of
most interest to vaccine development is the function of
the Ad E3 region, which is dispensable for virus growth
in tissue culture (Shenk, 1996) and is deleted routinely to
provide additional insertion space in vectors. The E3
region encodes a number of proteins that help the virus
evade the host immune system. The functions of some of
these proteins in human Ads (HAd) have been elucidated
and include the inhibition of MHC class I trafficking to the
cell surface, inhibition of TNF- function, and regulation
of apoptosis (reviewed in Horwitz, 2001). Deletion of E3
generally attenuates adenovirus infection, but in some
instances can lead to increased inflammatory responses
(Liu et al., 1988; Ginsberg et al., 1989).
The E3 region of canine adenovirus type 1 (CAV-1) is
located between nucleotides 24740 and 25719 and is
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26considerably smaller than that of HAd, containing two
open reading frames that encode polypeptides with pre-
dicted masses of 13.3 and 22.2 kDa (Dragulev et al., 1991;
Linne, 1992). The 13.3-kDa protein shows low level ho-
mology to a 12.5-kDa HAd protein of unknown function.
This homology extends to similar-sized E3 proteins from
other mammalian Ad species (Evans et al., 1998). The
22.2-kDa protein of CAV-1, however, shows no homology
to other E3 proteins.
The purpose of this work was to establish the feasi-
bility of using the E3 locus of CAV-1 as a site for the
expression of transgenes. We had previously cloned the
CAV-1 genome into a cosmid from which CAV-1 DNA
could be released by restriction endonuclease digestion
(Morrison et al., 1997). Transfection of this DNA into
canine cells resulted in infectious virus production. We
now report the generation of E3-deleted CAV-1 cosmid
clones using homologous recombination in bacterial
cells and insertion of canine parvovirus capsid expres-
sion cassettes at the E3 locus.
Results. Deleting regions within an adenoviral genome
can be a complex and multistep process using tradi-
tional cloning strategies. The method of Chartier and
colleagues (1996) employs recombination between two
linear DNA fragments to substitute sequences of DNA.
However, this method relies on the presence of a unique
restriction site at the locus of interest, to linearise thesize of 106 to 109% wild-type genome size for CAV-1. © 2
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target DNA, which limits its application. We have modi-
fied this protocol to include an antibiotic resistance geneon002 Elsev
as a selectable marker. This removes the necessity to
linearise the target DNA, thus allowing substitution of
any sequence within a cloned DNA.
Two subgenomic clones with 844- and 458-bp dele-
tions within the E3 region were made. In both constructs
the gene encoding chloramphenicol acetyltransferase
(CAT), flanked by recognition sites for the restriction
endonuclease PmeI, was cloned in place of the deleted
sequences. CAV-1 inserts were released from their plas-
mid backbones by restriction endonuclease digestion
and cotransformed with uncut cosmid 331 (containing
the wild-type CAV-1 genome) into recombinase-proficient
BJ5183 cells, and recombinants were selected for on
LB-agar plates supplemented with chloramphenicol, as
described in Fig. 1. Approximately 25% of the chloram-
phenicol-resistant colonies proved to be the desired con-
struct, dE3Cm or dE3sCm, with CAT in place of E3 se-
quences. Other colonies showed rearrangements or de-
letions within the CAV-1 genome (data not shown).
The CAV-1 genome in cosmid 331 is flanked by recog-
nition sites for the restriction endonuclease I-SceI. Trans-
fection of MDCK cells with I-SceI-digested 331 produces
viral cytopathic effect (cpe) after 7 to 10 days. Transfec-
tion of I-SceI-digested dE3Cm and dE3sCm also pro-
duced cpe; however, this took longer to appear (between
10 and 15 days), and to progress to 100% cpe, than
wild-type. PCR analysis of virus isolated from transfected
cells confirmed the deletions within the E3 locus and
restriction endonuclease digestion verified that there
were no other gross differences between the E3-deleted
genomes and the wild-type virus (data not shown).
Digestion of cosmids dE3Cm and dE3sCm by PmeI
released the CAT gene, producing cosmids dE3 and
dE3s, respectively. Viral cpe was observed when these
cosmids were digested with I-SceI and transfected into
MDCK cells. Plaques appeared within a time frame sim-
ilar to that of wild-type (7 to 10 days) and progressed to
100% cpe with similar kinetics.
The purpose of a gene therapy or vaccine vector is to
carry transgenes to a cellular target. Adenoviruses have
demonstrated ability to deliver and express transgenes
in cells both in vitro and in vivo (reviewed in Russell,
2000). Two cassettes expressing canine parvovirus cap-
sid protein were cloned into the dE3 backbone, one
under control of the rous sarcoma virus (RSV) promoter
(RSVC) and the other, the human cytomegalovirus (CMV)
immediate early promoter (CMVC). Transfection of MDCK
cells with I-SceI-restricted dE3RSVC led to the appear-
ance of plaques within 7 to 10 days (i.e., kinetics similar
to those of wild-type DNA and dE3/dE3s). In contrast,
following transfection of dE3CMVC, plaques were ob-
served only after 13 to 15 days of culture. Virus was
isolated from several of these transfections and sub-
jected to PCR (Fig. 2). dE3RSVC-derived virus showed
the expected band size of 3.1 kb; however, three separate
isolates from dE3CMVC transfections had band sizes of
approximately 0.6, 0.9, 1.2, 1.3, and 1.7 kb, compared with
an expected size of 4.0 kb (Fig. 2).
RNA was isolated from MDCK cells infected with
dE3RSVC and RT-PCR performed to confirm that parvo-
virus capsid was expressed from the CAV-1 backbone.
As a positive control, RNA was isolated from MDCK cells
transfected with the RSVC and CMVC plasmids. Positive
amplification of the expected 346-bp product was ob-
served with RNA from dE3RSVC-infected cells and from
cells transfected with the capsid expressing plasmids
(Fig. 3, lanes 1–5, RTase).
Wild-type RI261, 331-derived wild-type, dE3Cm, dE3,
FIG. 1. Cloning of E3-deletion constructs using CAT as a selectable marker. Cosmid 331 (containing the wild-type CAV-1 genome) was
cotransformed into BJ5183 cells (which are recombinase proficient) with either SacII-digested KXCm or EcoRI-digested 3.6dE3Cm. Both of these
constructs have regions upstream and downstream of the E3 deletion site flanking the CAT gene (as numbered above). Homologous recombination
replaced E3 sequences with CAT, producing cosmids dE3Cm and dE3sCm, respectively. The CAT gene could be removed by PmeI digestion, giving
cosmids dE3 and dE3s. The canine parvovirus capsid expression cassettes RSVC and CMVC were cloned into the PmeI site of dE3, producing
cosmids dE3RSVC and dE3CMVC, respectively.
27RAPID COMMUNICATION
and dE3RSVC viruses were used to infect MDCK cells
under one-step growth conditions (Fig. 4). With the ex-
ception of dE3Cm, all viruses were present in the cell-
associated fraction at similar levels following the 1-h
adsorption period (0 h) and cell-associated titres in-
creased between 12 and 18 h to reach a plateau 24 to
30 h postinfection. Extracellular titres increased after 18
to 24 h and, with the exception of dE3Cm, all monolayers
exhibited 100% cpe by 36 h.
Discussion. We have used a simple system to gener-
ate recombinant CAV-1 by manipulation of cosmid cloned
DNA in bacteria. Sequences as short as 360 bp flanking
the region of interest were sufficient for recombination in
BJ5183 cells (3.6dE3Cm sequences upstream of E3 de-
letion). This method allowed the replacement of the E3
region with a unique cloning site, which was used for the
insertion of cassettes expressing the canine parvovirus
capsid.
Two of the E3-deleted viruses analysed under one-
step growth conditions (dE3 and dE3RSVC) had growth
kinetics indistinguishable from those of wild-type CAV-1
(Fig. 4). This indicates that the E3 region in CAV-1 is
dispensable for growth in tissue culture, as has been
demonstrated for HAd (Shenk, 1996), and that the E3
locus is a suitable site for the insertion of transgenes.
Two other constructs, dE3Cm and dE3CMVC, showed
delayed growth relative to wild-type. dE3Cm stock titres
were 2 to 3 logs lower than those of wild type, dE3, and
dE3RSVC. One-step growth data indicated that dE3Cm
attachment to/entry into MDCK cells was impaired and
that although its growth kinetics were similar to those of
the other viruses, titres were at least 1 log lower at each
time point (Fig. 4). The reasons for this are unknown;
perhaps insertion of the CAT gene at the E3 locus is
associated with toxicity or interference with transcription
of viral genes such as the fibre.
PCR analysis of dE3CMVC indicated deletions within
the inserted capsid expression cassette (Fig. 2). One
possible explanation for this is that the CMVC insert
increases the viral genome size above the packaging
limits. Studies on HAd have indicated that a maximum of
105% wild-type genome size can be packaged, above
which DNA is deleted and rearranged to bring genome
size below this limit (Bett et al., 1993). This may not be
true for animal Ads, as an ovine Ad has been demon-
strated to package up to 114% of its genome size (Xu et
al., 1997). dE3RSVC and dE3CMVC have genome sizes of
106 and 109% of wild type, respectively, suggesting that
the maximum packaging size of CAV-1 falls between
these limits. Alternatively, instability at this site could be
attributed to differences in promoter strength. We have
no data to indicate that the CMV/intron A combination is
stronger than RSV, but if this were so this could interfere
with viral gene expression, acting as a selection pres-
sure for viruses lacking this promoter. Both scenarios
would explain the delayed growth of dE3CMVC. Further
investigation using different sized, transcriptionally inert
DNA would be required to confirm the packaging size
limits for CAV-1.
Materials and Methods. MDCK cells and CAV-1 virus
were cultured and prepared as described previously
(Morrison et al., 1997). Virus was titred using the TCID50
method and Karber formula.
Construction of cosmid 331 has been described before
(Morrison et al., 1997). Digestion of cosmid 331 by the
restriction endonuclease I-SceI liberates viral genomic
DNA, which yields infectious virus when transfected into
MDCK cells.
FIG. 3. RT-PCR of parvo capsid RNA isolated from MDCK cells. Lanes
1—transfected with 1 g RSVC, 2—transfected with 5 g RSVC,
3—transfected with 1 g CMVC, 4—transfected with 5 g CMVC,
5—infected at a m.o.i. of 10 with dE3RSVC virus, 6—water control.
Transfected cells were harvested at 48 h and infected cells at 4 h. RNA
was extracted using Gentra’s Purescript kit, DNase treated, and re-
verse transcribed and amplified using Promega’s Access kit. RTase
controls were performed to check for DNA contamination. MW—1 kb
molecular weight marker.
FIG. 2. PCR of E3-deleted viruses containing parvovirus capsid
expression cassettes. DNA was isolated from MDCK cells that had
been transfected with dE3CMVC and dE3RSVC cosmids and were
exhibiting viral cpe and subjected to PCR using primers E3delup and
E3del2. PCR was performed on cosmids dE3CMVC, dE3RSVC, dE3,
and 331 for comparison. MW—1 kb molecular weight marker.
28 RAPID COMMUNICATION
The E3 region of CAV-1 is located between nucleotides
24740 and 25719. Two subgenomic plasmids with dele-
tions at the E3 locus were constructed in pBluescript.
KXCm contains CAV-1 sequence from nucleotide 23127
(KpnI site) to 27152 (XbaI site) with E3 sequences be-
tween 24870 and 25714 deleted, and 3.6dE3Cm contains
CAV-1 sequence from nucleotide 24796 to 28322 with E3
sequences between 25155 and 25613 deleted. In each
construct the gene encoding CAT from pBSL119 (Alex-
eyev et al., 1995), and flanked by PmeI sites, was cloned
in place of the deleted E3 sequences.
KXCm and 3.6dE3Cm were restricted by SacII and KpnI,
respectively, and the inserts gel-purified from the pBlue-
script backbone. Approximately 0.5 g of either the KXCm
or the 3.6dE3Cm insert was electroporated with 1.5 g of
uncut cosmid 331 into freshly prepared, electrocompetent
BJ5183 cells, using standard protocols (Ausubel et al., 1993).
Recombinant clones were selected on LB agar plates con-
taining 100 g per ml chloramphenicol (Fig. 1). DNA from
positive clones was subsequently used to transform Stbl-2
cells (Life Technologies), as BJ5183 cells produced low
yields of cosmid and propagation of these constructs in
BJ5183 cells led to deletions and rearrangements.
Two mammalian expression cassettes encoding the
canine parvovirus capsid were cloned into the E3 locus
(Fig. 1). RSVC has expression driven by the Rous sar-
coma virus promoter and CMVC has expression driven
by the CMV promoter and intron A. The respective sizes
of these inserts are 2568 and 3451 bp.
The sequences of constructs and virus isolates were
determined using an automated fluorescence sequencer
(Licor) as described previously (Morrison et al., 1997).
FIG. 4. One-step growth curves for wild-type (RI261 and 331) and E3-deleted CAV-1. MDCK cells were infected at a m.o.i. of 10. At each time point
the medium was removed, the cell monolayer was washed twice with PBS, and the cells were removed by trypsin. Cell-associated virus was released
by three cycles of freeze–thawing. TCID50 values for total virus in cellular and extracellular fractions are presented for each time point. RI261—original
wild-type CAV-1 isolate (Morrison et al., 1997).
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To recover viruses, MDCK cells, seeded 24 h prior to
transfection, at 5  105 cells per 25-cm2 flask, were
transfected with approximately 5 g of I-SceI-digested
cosmid and 30 l of Lipofectamine (Life Technologies),
following the manufacturer’s protocol.
Aliquots of supernatant from flasks showing cpe were
removed, diluted 1:10 with dH2O, and heated at 95°C for
15 min to disrupt capsids. Samples were subjected to 35
cycles of 30 s denaturation at 95°C, 30 s annealing at
55°C, and 2 min elongation at 72°C; followed by a final
7-min elongation step at 72°C. Primers E3delup (GGG-
GATGATTCAGTGAGACC, nucleotides 24689 to 24710)
and E3del2 (CCTTTCCTGACCAATTCATCCC, nucleotides
26008 and 25989) were used to amplify the E3 region.
RT-PCR was performed on RNA extracted from cells
transfected with RSVC and CMVC or infected with
dE3RSVC (Fig. 3). Cycling conditions were as follows: 45
min at 48°C for reverse transcription; followed by a 5-min
94°C step to denature the RTase and 45 cycles of 30 s at
94°C, 30 s at 55°C, and 1 min at 68°C. The primers 5
ACTGGAACTAGTGGCACACC 3 (nucleotides 667 to 686
of capsid gene) and 5 AACCAACCTCAGCTGGTCTC 3
(nucleotides 1012 to 993 of capsid gene), giving an ex-
pected product size of 346 bp, were used.
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